NT_1170x120_1-11-18

CastiaRx

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

FLINT, Mich. — Diplomat Pharmacy is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco. Diplomat now expects 2018 revenue to be at the lower end of the previously communicated $5.5 to $5.7 billion range and adjusted EBITDA to be at

Diplomat launches CastiaRx, leading specialty benefit manager

Diplomat launches CastiaRx, leading specialty benefit manager

FLINT, Mich. — Diplomat Pharmacy has unveiled CastiaRx to respond to industry demand for a leader in specialty benefit management. CastiaRx unites the full-service pharmacy benefit manager (PBM) capabilities of recently acquired LDI Integrated Pharmacy Services and National Pharmaceutical Services with Diplomat’s specialty pharmacy and infusion expertise. According to the IQVIA Institute for Human Data